Recida Therapeutics
Latest round
- Series A
Last raised
- Feb 2019
Total raised
- $8.5M
Investors
- 1
About Recida Therapeutics
Founded in 2016 and based in California, US, Recida Therapeutics, Inc. is a biopharmaceutical company that develops anti-infective medicines for multi-drug resistant infections. The company's program RC-01, an IND-stage LpxC inhibitor to treat multidrug-resistant gram-negative infections. RC-01 prevents bacterial LpxC, an enzyme in Lipid A biosynthesis, which is an essential component of the outer membrane of gram-negative bacteria for its survival.
Who invested in Recida Therapeutics
1 investor across 1 round
See all investors in Recida Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 6, 2019
Amount
$8.5M
Investors
Questions about Recida Therapeutics
Who invested in Recida Therapeutics?
Recida Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Recida Therapeutics raised?
Recida Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Recida Therapeutics last raise money?
Recida Therapeutics's most recent round on record is a Series A, in Feb 2019.
What does Recida Therapeutics do?
Founded in 2016 and based in California, US, Recida Therapeutics, Inc.
Where is Recida Therapeutics headquartered?
Recida Therapeutics is headquartered in Menlo Park, US.
Which VCs invest in companies like Recida Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Recida Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Recida Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.